InMed Pharmaceuticals Inc.
Suite 340 – 200 Granville St.
Vancouver, BC V6C 1S4 Canada
Member Sector: Biopharmaceuticals
InMed is a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems. InMed conducts research, discovery, preclinical, clinical, regulatory, manufacturing and commercial development activities for its product candidates. InMed’s proprietary bioinformatics database assessment tool, the biosynthesis manufacturing process and its drug development programs are the fundamental value drivers of the Company.